Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Phase I Study of Milatuzumab for Graft Versus Host Disease
- Status
- TERMINATED
- Phase
- PHASE1
Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participants With Relapsed/Refractory NHL and CLL
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy and Safety of Single Agent GS 1101 (CAL 101) as Therapy for Previously Treated Chronic Lymphocytic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Long-term Efficacy Study of Sodium Channel Blocker in LQT3 Patients
- Status
- COMPLETED
- Phase
- PHASE2
Symptomatic Pulmonary Arterial Hypertension After Mitral Valve Surgery
- Status
- COMPLETED
- Phase
- N/A
Lenalidomide and Idelalisib in Treating Patients With Recurrent Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF
- Status
- COMPLETED
- Phase
- PHASE3
Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3
A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure
- Status
- COMPLETED
- Phase
- PHASE4
Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies
- Status
- COMPLETED
- Phase
- PHASE3
Study to Characterize the Durability of Hypertonic Saline to Enhance Mucociliary Clearance in Healthy Subjects
- Status
- COMPLETED
- Phase
- NA
Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis
- Status
- TERMINATED
- Phase
- NA
Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of Labetuzumab Govitecan in Participants With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV
- Status
- TERMINATED
- Phase
- PHASE4